Electronic health record (EHR) algorithms for defining patient cohorts are commonly shared as free-text descriptions that require human intervention both to interpret and implement. We developed the Phenotype Execution and Modeling Architecture (PhEMA, http://projectphema.org) to author and execute standardized computable phenotype algorithms. With PhEMA, we converted an algorithm for benign prostatic hyperplasia, developed for the electronic Medical Records and Genomics network (eMERGE), into a standards-based computable format. Eight sites (7 within eMERGE) received the computable algorithm, and 6 successfully executed it against local data warehouses and/or i2b2 instances. Blinded random chart review of cases selected by the computable algorithm shows PPV 90%, and 3 out of 5 sites had >90% overlap of selected cases when comparing the computable algorithm to their original eMERGE implementation. This case study demonstrates potential use of PhEMA computable representations to automate phenotyping across different EHR systems, but also highlights some ongoing challenges.
INTRODUCTION
Electronic health records (EHRs) are designed primarily for clinical care and operations, which introduces limitations to the data when used for secondary purposes. These include data availability, accuracy, and information available only in unstructured narrative text. [1] [2] [3] To navigate these issues, researchers often develop "phenotype algorithms"-a set of criteria that specifies the analysis of data for identifying and studying patient populations with a given biomedical condition or indication. 4, 5 When replication of results or additional statistical power is needed, a phenotype algorithm may be shared with other institutions for execution on their EHR data, using various methods and tools. 6 A common method used to share algorithms is as free-text descriptions of the algorithmic logic, possibly augmented with flowcharts and lists of codes from medical vocabularies. Implementing this description in a computable form (such as a database query) requires humans to interpret and make decisions for deployment, which can be error prone and time consuming. 7 An approach pursued via common data models (CDMs) is to organize EHR data according to a common standard. CDMs, such as those used by Observational Health Data Sciences and Informatics (OHDSI), 8 the National Patient-Centered Clinical Research Network (PCORnet), 9 and Informatics for Integrating Biology & the Bedside's (i2b2's) 10 Shared Health Research Informatics NEtwork (SHRINE), 11 can enable cross-site queries since the semantic and syntactic data organization is shared, but requires transforming data to the CDM. Within the electronic Medical Records and Genomics (eMERGE) network, 12 the Phenotype KnowledgeBase (PheKB) 13 
METHODS

BPH phenotype algorithm
BPH was chosen as a test phenotype for PhEMA in part because the case identification algorithm contains 4 of the most commonly used EHR data elements (demographics, diagnoses, procedures, and medications), all of the Boolean logical operators (And, Or, Not), a temporal relationship (age), and one aggregation function (count). Since the majority of sites in this study recently executed the algorithm for eMERGE, it also provided a baseline for comparisons against the results using PhEMA. A single institution (Vanderbilt University) defined the original BPH phenotype algorithm for the eMERGE study (referred to as the "original algorithm"), which was modified by the authors for implementation within PhEMA (referred to as the "PhEMA algorithm"). The PhEMA algorithm used a combination of standard medical terminology codes for medications (RxNorm and NDC), diagnostic codes (ICD-9), and procedure codes (CPT). Although the original algorithm used natural language processing (NLP) on patients' problem lists, NLP was not included in the PhEMA algorithm due to a lack of standard representations of NLP. 16 The study population was defined as males age 40 and older who had no evidence in their EHR of prostate, penile, urethral, or bladder cancer. Within the PhEMA algorithm, the exclusion used just ICD-9 billing codes, although the original algorithm also used ICD-O-3 codes from tumor registries and mentions of these cancers in the problem list. The PhEMA algorithm selected only cases defined as those in the study population with any BPH-related ICD-9 codes on 2 separate days, plus at least one BPH medication or BPH-related surgery code ( Figure 1 ).
Translation of algorithm into a standardized, executable format
The modified PhEMA algorithm to detect BPH cases was represented using the PhEMA Authoring Tool (PhAT) (available at: https://github.com/PheMA/bph-use-case), by one of the authors (LVR). Since PhEMA relies on the presence of value sets (groups of medical terminology codes) to represent different medical concepts (eg, medications, diagnoses), we first looked at the Value Set Authority Center (VSAC) 17 for existing value sets. Outside of the value set of "Male," no existing value sets met the need of our algorithm; therefore, the authors defined and published the necessary value sets within the VSAC for general use (also available at: https:// github.com/PheMA/bph-use-case). Given the use of QDM 4.1 16, 18 within PhEMA, which accounts for the status of a data element (eg, an active diagnosis, as opposed to the more abstract "diagnosis"), we included in our definition the relevant statuses for diagnoses, medications, and procedures. This approach allows a more precise algorithm definition, as it removes the ambiguity of which statuses are appropriate. The phenotype definition was exported from the PhAT into 2 executable KNIME workflows (KNIME AG, Zurich Switzerland, Figure 2 ): 1 workflow executed query definitions using i2b2 messaging ( Figure 2A ), and the other executed against an LDW ( Figure 2B ). KNIME was chosen as the execution engine, as it is freely available, runs on multiple operating systems, and, most importantly, can connect directly to external systems that expose a web API. Furthermore, KNIME uses a modular graphical workflow interface that allows encapsulation of algorithm logic (the same across sites) from configuration details (variable between sites), allowing each site to configure the connection to its data without having to edit the algorithm's logic. 18, 19 Upon review of the exported KNIME workflows, we identified opportunities to optimize their execution before distributing to sites. First, within sites' i2b2 instances, diagnosis status (active, resolved, or inactive) was not explicitly described; thus, the 3 queries (1 for each status) were collapsed into a single query. Second, by default, Figure 2 . KNIME workflows that read data from either an i2b2 instance (A), or an LDW (B), and execute the BPH case algorithm. After users complete configurations specific to their sites within these workflows, including database connection details (server address, username, password, etc.) and any necessary data customization, the user executes the entire KNIME workflow in one step. Upon execution, each QDM Data Element node reads in the i2b2, or LDW, connection details, and i2b2 ontology mapping, or LDW, queries the users modified and extracts the relevant data, after which the subsequent nodes execute the algorithm logic. On the far right of each workflow in the XLS Writer node: users can specify a filename to which to write the identifiers of the patients with BPH as found by the algorithm. A: i2b2: Table Creator node on the top left is where users enter their i2b2 connection details. Below that node, the "OIDs to i2b2 ONT" metanode is where users make adjustments, if necessary, to the i2b2 ontology mapping. This workflow that executes against the publicly available demonstration version of i2b2 is available at: https://github.com/PheMA/bph-use-case B: LDW: Database Connector node on the top left is where users enter their LDW connection details. Then, within each QDM Data Element metanode, users open a Database Table Selector node, in which the value set for that data element is available as a variable, and edit the template query in that node to query the appropriate data for that data element from their LDW [eg, edit the template query "select diagnois_co-de_column from diagnois_table where diagnosis in (diagnois_list_variable)" by replacing the column and table names (in italics) with the column and tables names in the LDW].
the workflow returned multiple types of results within i2b2 for each query-a count, a list of patients, and a list of events. We edited the workflow to return only patient sets, to further reduce execution time. Finally, we removed the temporal relationship between BPH diagnoses and instead required patients to have 2 BPH diagnoses, as some sites did not have visits associated with diagnoses in their i2b2 data.
Once given to the implementation site, each workflow required up to 2 local customization steps. First, the site must specify the connection details for its repository (i2b2 or LDW). Second, the site performed data customization if needed. For i2b2, this involved updating the ontology mapping so the correct concepts could be found, and for the LDW, editing template data queries to return the required data elements. Two members of the PhEMA team (JAP, LVR) guided this customization via remote screen sharing.
Execution of PhEMA BPH algorithm
Eight sites (Columbia, Cornell, Geisinger, Harvard, Marshfield, Mayo, Northwestern, and Vanderbilt), executed the PhEMA BPH algorithm. Five eMERGE sites were able to assess if the same eMERGE subjects were identified by both their earlier custom implementation of the eMERGE BPH algorithm and the PhEMA implementation. To evaluate accuracy, we conducted manual blinded review of randomly selected cases using the chart abstraction form used for validating the eMERGE algorithm.
RESULTS
Execution
Of the 8 sites, 5 executed the algorithm against their i2b2 repository, and 4 executed the algorithm against their LDW (Northwestern executed against both). Table 1 shows the number of cases identified using PhEMA, along with the number of males 40 years old in each site's data repository. Two sites (Harvard, Mayo) were unable to completely execute the KNIME workflow.
Validation
Due to resource limitations, not all sites were able to perform a chart review. Results for those sites completing chart reviews are shown in Table 1 . Three sites had validated the eMERGE implementation of the algorithm. The eMERGE case PPV was 100% at 2 of these 3 sites, and >80% at Northwestern (Table 1) . Of the 4 sites that completed a chart review of the PhEMA implementation, all 4 sites reported PPV 90% with Northwestern increasing overall PPV for cases in their PhEMA implementation, and Vanderbilt decreasing. Figure 3 shows the assessment of overlap in the cases between the eMERGE and PhEMA algorithm implementations for the 5 sites that successfully implemented both versions. Overall, we found that 3 sites had at least 90% overlap, and 2 sites had approximately half overlapping.
DISCUSSION
The 90% overlap at 3 of those 5 sites, and the fact that all of the PhEMA implementation case PPVs were 90%, a threshold often used in genetic studies, 4, 7 demonstrates the accuracy of PhEMA, and its ability to reproduce manual algorithm implementation results using a standardized computable format. We anticipated some differences due to the modifications of the algorithm, and PhEMA's current inability to handle NLP. Further discrepancies at Marshfield and Northwestern were traced to different interpretation and implementation of the eMERGE algorithm than originally intended (excluding all inclusion events at ages less than 40, omission of some ICD-9 and CPT codes, or requiring diagnoses to be made by the institution's providers). This did not greatly impact the validity of either eMERGE or PhEMA implementations, as PPV was sufficient in both instances (Table 2) . However, the interpretation differences highlight the importance of the goal of PhEMA to produce computable portable phenotype algorithms, which eliminate the need for human interpretation of free text. Although current algorithm methodology can and does result in PPVs that demonstrate sufficient accuracy to power GWAS, [20] [21] [22] [23] [24] [25] [26] [27] PhEMA seeks to improve the efficiency and portability of executing across different sites by producing computable algorithms; however, manual site-specific configuration was needed. Informal observation suggests that executing a PhEMA phenotype takes less time to implement than a corresponding free-text description, although additional time is required by the algorithm author to create a computable definition using PhAT. For example, Geisinger configured and executed the PhEMA implementation in less than a day, which was considerably less time than it took to create the custom implementation for eMERGE. Our approach can be compared to networks with a CDM for which similar successes have been reported for portable, computable phenotype algorithms, but with the requirement that all sites have a pre-coordinated data model. 28, 29 Most of the difficulties we had in executing across sites were technical. Table 2 details 5 of the largest issues that we worked through with sites. We purposefully limited the amount of time to troubleshoot issues as a proxy measure for portability, and thus marked Harvard's and Mayo's executions as unable to complete. Mayo's issue provided insight that the de-compositional approach used to construct our workflows extracted patients separately for each data element (eg, all males, all individuals >¼40 years old, etc.), then joined them all together, rather than use a stepwise approach to find patients with the first data element (males), and then of those patients with the second data element (males >¼40 years old). Additional notes regarding our analyses of these issues are available in Table 2 .
Finally, because selecting a random subset from the entire population for manual review was not feasible, our methodology for selection of charts for manual review was biased. We selected only from cases found by the execution of our phenotype algorithms, plus at some sites from a convenience sample (eMERGE subjects). A cursory review by site implementers would allow them to determine which terminology(ies) they did not have loaded.
Manually edit the terms used in a value set to include the local terms for the institution. (eg, manually identify all NDC codes related to the RxNorm codes for medications, then add those NDC codes to the list of terms in the medication value set) The Harvard development server was able to execute the workflow, but the production instance returned an HTTP 503 "Service Unavailable" error.
After engaging the site's server team, no additional information was available to explain this error. Even when the server was returning a 503 response to the KNIME workflow, the i2b2 web client that uses the same services was available and responsive. This indicated that the actual service was available, but may be responding in this way to the frequency of the requests from KNIME.
This has not yet been resolved. KNIME workflow would not complete execution against the Mayo i2b2 instance.
The i2b2 instance was the largest of the sites involved with this study, at over 9 million patients. We confirmed that this was not a limitation of the i2b2 platform, by manually creating and executing the BPH algorithm using the i2b2 web interface. Instead, we identified scalability issues with our KNIME workflow construction process, which led to computational bottlenecks, especially when processing queries against a repository of this size.
This has not yet been resolved.
Execution speed of the workflow is slow. Given the decompositional nature of the query, for which individual criteria are each queried and then later combined, we confirmed that the overall execution time would be increased compared to executing a single, final query.
Future work includes improving our execution platform to increase overall speed.
Unable to connect to the local data warehouse.
Sites frequently received connection errors. When working with sites to resolve these, we identified that they were legitimate errors, but that the way they were reported back to users was not helpful and did not offer any resolution.
Future work includes improving the feedback from the execution platform to describe (if possible) what may be causing a connection issue.
Future work
Given the lessons learned here, the PhEMA project is restructuring our approach to executing phenotype algorithms. We are developing an execution architecture that will better leverage efficiencies that can be gained by providing the entire (or large portions of the) phenotype query to the underlying database system. In addition, we are expanding our support for the other common data models, such as OMOP/OHDSI, for further cross-platform compatibility.
CONCLUSION
This case study demonstrates that a phenotype authoring system, such as PhEMA, could result in efficient and accurate implementations of EHR phenotype algorithms across multiple sites, and support differences in underlying data repositories. In this study, we identified some limitations in the current execution approach, which will provide guidance in future development.
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